Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Suzy Dilly, CEO, ValiRx
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Suzy Dilly, ValiRx CEO reiterates her support for TheoremRx and hails 'brilliant science' Cytolytix
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Understanding the Updated W-4 Form |Christine A. Centeno, Founder, Simplicity Wealth Management LLC.
00:10:00
Questioning the Manager: Exploring Investment Opportunities with James Henderson
00:10:00
Exploring the Future of Smart Cities: Interview with Rob Mostert at the ICANN Conference in Madrid
00:10:00
Exploring the Dynamic Terrain of Global Digital Infrastructure | Marc Ganzi , CEO ,DigitalBridge Group Inc.
00:10:00
Reward Minerals CEO Lorry Hughes discusses potential acquisition of Beyondie Sulphate of Potash (SOP) Project in Western Australia and the adaptation of potash processing technology.|MR LORRY HUGHES CHIEF EXECUTIVE OFFICER of Reward Minerals
00:10:00
David Hampstead on Samarkand Global's Strategic Partnership with S.F. Holding and Recent Brand Acquisitions | David Hampstead, CEO , Samarkand Global PLC.
00:10:00
private equity deals focused on emerging restaurants beverages services|Don Thompson,CEO,Cleveland Avenue
00:10:00
Promoting Mental Fitness and Connection in the Mining Industry
00:10:00
Liontown Resources: Gunda Cim Ilmenite Mine Restart and Offtake Agreement Details
00:00:00
WGBY features an overview of FuelCell Energy, highlighting its operations and significance within the energy sector | JASON FEW, PRESIDENT, CHIEF EXECUTIVE OFFICER, FUELCELL ENERGY INC
00:10:00
2024 Midyear Outlook: Waves of Transformation | BlackRock Bottom Line
00:10:00
Analyzing the Federal Reserve's Landing and Economic Outlook | Scott Sperling, CO-CEO, Thomas H. Lee Partners .